Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03XBB
|
||||
Former ID |
DIB012839
|
||||
Drug Name |
DX-2400
|
||||
Synonyms |
DX-2410; MMP inhibitors (fully human antibodies), Dyax
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Investigative | [1] | ||
Company |
Dyax Corp
|
||||
Target and Pathway | |||||
Target(s) | Matrix metalloproteinase-14 | Target Info | Inhibitor | [1] | |
KEGG Pathway | TNF signaling pathway | ||||
GnRH signaling pathway | |||||
PANTHER Pathway | Alzheimer disease-presenilin pathway | ||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
Signaling events mediated by focal adhesion kinase | |||||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
WikiPathways | Senescence and Autophagy in Cancer | ||||
Activation of Matrix Metalloproteinases | |||||
Degradation of collagen | |||||
AGE/RAGE pathway | |||||
Matrix Metalloproteinases | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1638). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.